Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis

Journal of Rheumatology

Volumn 39, Issue 6, 2012, Pages 1231-1237

  Kiani, Adnan N ^a   Wu, Tianfu ^b   Fang, Hong ^a   Zhou, Xin J ^d   Ahn, Chul W ^b   Magder, Laurence S ^c   Mohan, Chandra ^b   Petri, Michelle ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Lipocalin; Lupus nephritis; Neutrophil gelatinase associated lipocalin; Systemic lupus erythematosus; Vascular cell adhesion molecule

Indexed keywords

BIOLOGICAL MARKER; CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; CAUCASIAN; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISPANIC; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SEROLOGY; SEX RATIO; SLE DISEASE ACTIVITY INDEDX RENAL DESCRIPTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS RENAL ACTIVITY SCORE; VISUAL ANALOG SCALE;

ACUTE-PHASE PROTEINS; ADULT; BIOLOGICAL MARKERS; FEMALE; HEALTH STATUS; HUMANS; KIDNEY; LIPOCALINS; LUPUS NEPHRITIS; MALE; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; SEVERITY OF ILLNESS INDEX; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84861812628     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.111470     Document Type: Article

References (42)

1. Austin HA, Boumpas DT, Vaughan EM, Balow JE. High-risk features of lupus nephritis: Importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 1995;10:1620-8.
2. Dooley MA, Hogan S, Jennette C, Falk R. Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans. Glomerular Disease Collaborative Network. Kidney Int 1997;51:1188-95. (Pubitemid 27186545)
3. Bastian HM, Alarcon GS, Roseman JM, McGwin G Jr, Vila LM, Fessler BJ, et al. Systemic lupus erythematosus in a multi-ethnic US cohort (LUMINA) XLII: Factors predictive of new or worsening proteinuria. Rheumatology 2007;46:683-9. (Pubitemid 46523317)
4. Cameron JS. Lupus nephritis. J Am Soc Nephrol 1999;10:413-24. (Pubitemid 29068083)
5. Ward MM. Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995. Arch Intern Med 2000;160:3136-40.
6. Ward MM. Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996-2004. J Rheumatol 2009;36:63-67.
7. Moroni G, Pasquali S, Casanova S, Zucchelli P, Ponticelli C. Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis 1999;34:530-9. (Pubitemid 29413627)
8. Wuthrich RP. Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int 1992;42:903-14.
9. Wu T, Xie C, Bhaskarabhatla M, Yan M, Leone A, Chen SS, et al. Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum 2007;56:949-59. (Pubitemid 46399442)
10. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003;14:2534-43. (Pubitemid 37169339)
11. Ka SM, Rifai A, Chen JH, Cheng CW, Shui HA, Lee HS, et al. Glomerular crescent-related biomarkers in a murine model of chronic graft versus host disease. Nephrol Dial Transplant 2006;21:288-98. (Pubitemid 43159981)
12. Brunner HI, Mueller M, Rutherford C, Passo MH, Witte D, Grom A, et al. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum 2006;54:2577-84. (Pubitemid 44205019)
13. Pitashny M, Schwartz N, Qing X, Hojaili B, Aranow C, Mackay M, et al. Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheum 2007;56:1894-903. (Pubitemid 47110388)
14. Devarajan P. Review: Neutrophil gelatinase-associated lipocalin: A troponin-like biomarker for human acute kidney injury. Nephrology 2010;15:419-28.
15. Ohlsson S, Wieslander J, Segelmark M. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies- associated systemic vasculitis in remission. Clin Exp Immunol 2003;131:528-35. (Pubitemid 36324145)
16. Biezeveld MH, van Mierlo G, Lutter R, Kuipers IM, Dekker T, Hack CE, et al. Sustained activation of neutrophils in the course of Kawasaki disease: An association with matrix metalloproteinases. Clin Exp Immunol 2005;141:183-8. (Pubitemid 40904656)
17. Stoesz SP, Friedl A, Haag JD, Lindstrom MJ, Clark GM, Gould MN. Heterogeneous expression of the lipocalin NGAL in primary breast cancers. Int J Cancer 1998;79:565-72. (Pubitemid 28549466)
18. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 1996;38:414-20.
19. Furutani M, Arii S, Mizumoto M, Kato M, Imamura M. Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett 1998;122:209-14. (Pubitemid 28058638)
20. Lim R, Ahmed N, Borregaard N, Riley C, Wafai R, Thompson EW, et al. Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer 2007;120:2426-34. (Pubitemid 46642130)
21. Mishra J, Ma Q, Kelly C, Mitsnefes M, Mori K, Barasch J, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 2006;21:856-63. (Pubitemid 43740956)
22. Trachtman H, Christen E, Cnaan A, Patrick J, Mai V, Mishra J, et al. Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: A novel marker of renal injury. Pediatr Nephrol 2006;21:989-94. (Pubitemid 43885099)
23. Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin: A novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004;24:307-15. (Pubitemid 39070114)
24. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S. Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 2006;26:287-92. (Pubitemid 44121091)
25. Wu T, Xie C, Wang HW, Zhou XJ, Schwartz N, Calixto S, et al. Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol 2007;179:7166-75.
26. Ikeda Y, Fujimoto T, Ameno M, Shiiki H, Dohi K. Relationship between lupus nephritis activity and the serum level of soluble VCAM-1. Lupus 1998;7:347-54. (Pubitemid 28347015)
27. Wuthrich RP. Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int 1992;42:903-14.
28. Nakatani K, Fujii H, Hasegawa H, Terada M, Arita N, Ito MR, et al. Endothelial adhesion molecules in glomerular lesions: Association with their severity and diversity in lupus models. Kidney Int 2004;65:1290-300. (Pubitemid 38406967)
29. Seron D, Cameron JS, Haskard DO. Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant 1991;6:917-22.
30. Brady HR. Leukocyte adhesion molecules and kidney diseases. Kidney Int 1994;45:1285-300. (Pubitemid 24135013)
31. Hillis GS, Duthie LA, Brown PA, Simpson JG, MacLeod AM, Haites NE. Upregulation and colocalization of connexin 43 and cellular adhesion molecules in inflammatory renal disease. J Pathol 1997;182:373-9. (Pubitemid 27317200)
32. Bechtel U, Scheuer R, Landgraf R, Konig A, Feucht HE. Assessment of soluble adhesion molecules (sICAM-1, sVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine. Clinical monitoring of renal allograft recipients. Transplantation 1994;58:905-11. (Pubitemid 24333281)
33. Abd-Elkareem MI, Al Tamimy HM, Khamis OA. Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: Preliminary findings. Clin Exp Nephrol 2010;14:548-57.
34. Spronk PE, Bootsma H, Huitema MG, Limburg PC, Kallenberg CG. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Clin Exp Immunol 1994;97:439-44. (Pubitemid 24283887)
35. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al: OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005;353:2550-8. (Pubitemid 41785892)
36. Petri M, Hellmann D, Hochberg M. Validity and reliability of lupus activity measures in the routine clinic setting. J Rheumatol 1992;19:53-9.
37. Petri M, Kasitanon N, Lee SS, Link K, Magder L, Bae SC, et al Systemic Lupus International Collaborating Clinics. Systemic lupus international collaborating clinics renal activity/response exercise: Development of a renal activity score and renal response index. Arthritis Rheum 2008;58:1784-8. (Erratum in: Arthritis Rheum 2008;58:2823). (Pubitemid 351847532)
38. Alpers CE, Hudkins KL, Davis CL, Marsh CL, Riches W, McCarty JM, et al. Expression of vascular cell adhesion molecule-l in kidney allograft rejection. Kidney Int 1993;44:805-16. (Pubitemid 23290522)
39. Molad Y, Miroshink E, Sulkes J, Pitlik S, Weinberger A, Monselise Y. Urinary soluble VCAM-1 in systemic lupus erythematosus: A clinical marker for monitoring disease activity and damage. Clinic Exp Rheumatol 2002;20:403-6. (Pubitemid 35012578)
40. Austin HA, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome. Kidney Int 1984;25:689-95. (Pubitemid 14079965)
41. Austin HA, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 1983;75:382-91. (Pubitemid 13005770)
42. Contreras G, Pardo V, Cely C, Borja E, Hurtado A, De La Cuesta C, et al. Factors associated with poor outcomes in patients with lupus nephritis. Lupus 2005;14:890-5. (Pubitemid 41736370)